Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
The Lancet. Infectious Diseases|August 30, 2018
Incidence, aetiology, and sequelae of viral meningitis in UK adults: a multicentre prospective observational cohort studyFiona McGill, Michael J Griffiths, Laura J Bonnett, et al.Applied Health Economics and Health Policy|November 8, 2019
Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of OlaratumabCaridad Pontes, Corinne Zara, Josep Torrent-Farnell, et al.Frontiers in Pharmacology|February 25, 2021
Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the ImplicationsIsrael Abebrese Sefah, Olayinka O Ogunleye, Darius Obeng Essah, et al.Expert Opinion on Pharmacotherapy|November 26, 2019
Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countriesBrian Godman, Christoffel Grobler, Marianne Van-De-Lisle, et al.Frontiers in Pharmacology|October 14, 2016
Payers' Views of the Changes Arising through the Possible Adoption of Adaptive PathwaysMichael Ermisch, Anna Bucsics, Patricia Vella Bonanno, et al.Expert Review of Pharmacoeconomics & Outcomes Research|January 31, 2019
Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTAPatricia Vella Bonanno, Anna Bucsics, Steven Simoens, et al.Frontiers in Pharmacology|September 8, 2017
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential ImplementationPatricia Vella Bonanno, Michael Ermisch, Brian Godman, et al.Current Medical Research and Opinion|December 4, 2019
Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the futureBrian Godman, Mainul Haque, Judy McKimm, et al.Frontiers in Public Health|December 21, 2018
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited BudgetsBrian Godman, Anna Bucsics, Patricia Vella Bonanno, et al.Expert Review of Pharmacoeconomics & Outcomes Research|February 4, 2021
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implicationsBrian Godman, Andrew Hill, Steven Simoens, et al.Pageof 5